Public Health Market Partnering 2016 Deal Trends and Players' Analysis Research Report

Mar 28, 2016, 06:00 ET from ReportsnReports

PUNE, India, March 28, 2016 /PRNewswire/ --

Global Public Health Partnering 2010 to 2016 provides the full collection of Public Health disease deals signed between the worlds pharmaceutical and biotechnology companies since 2010 till 2016.

Complete report on public health market divided into 6 major chapters that offer an overview of current market scenario as well as forecasts along with data figures is now available at

Global Public Health Partnering 2010 to 2016 includes: Trends in Public Health partnering deals; Financial deal terms for headline, upfront and royalty by stage of development; Public Health partnering agreement structure; Public Health partnering contract documents; Top Public Health deals by value; Most active Public Health dealmakers.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Public Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Public Health deals.

The report presents financial deal terms values for Public Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals. Order a copy of this report at "Delivery of this report will take 1-3 days after purchase."

The initial chapters of this report provide an orientation of Public Health dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Public Health dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Public Health deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Public Health dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Public Health deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Public Health partnering deals by specific Public Health target announced since 2010. The chapter is organized by specific Public Health therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Public Health partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Public Health partnering and dealmaking since 2010.

In Global Public Health Partnering 2010 to 2016, available deals and contracts are listed by: Headline value, Upfront payment value, Royalty rate value, Stage of development at signing, Deal component type, Technology type and Specific therapy indication

Explore other reports on healthcare market at

On a related note, the Health Care Markets in China research report ( ) examines China''s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+1 888 391 5441

Connect With Us on:
G+ / Google Plus:

SOURCE ReportsnReports